Active ingredientTazaroteneCat. No. P-T023-001CAS 118292-40-3Family · Pharmaceutical analytical standards
Tazarotene
A third-generation acetylenic topical retinoid, a prodrug that becomes tazarotenic acid in the skin; approved in 1997, it is used for plaque psoriasis and acne. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was the first 'receptor-selective' topical retinoid for psoriasis: instead of activating all retinoic acid receptors, it acts mainly on RAR-beta and RAR-gamma.
Go to the active ingredient →Active ingredientTazaroteneCat. No. P-T023-001CAS 118292-40-3
Isotopically labelledTazarotene-d6Cat. No. P-T023-002CAS 1246815-76-8
Isotopically labelledTazarotenic Acid-d6Cat. No. P-T023-003CAS 1794760-38-5
Impurity6-bromo-4,4-dimethylthiochromanCat. No. P-T023-004CAS 112110-44-8
Impurity6-Ethynyl-4,4-dimethylthiochromanCat. No. P-T023-005CAS 118292-06-1
ImpurityEthyl 4-chlorobenzoateCat. No. P-T023-006CAS 7335-27-5
ImpurityTazarotene Impurity 1Cat. No. P-T023-007
ImpurityTazarotene Impurity 2Cat. No. P-T023-009
ImpurityTazarotene Impurity 3Cat. No. P-T023-010
ImpurityTazarotene SulfoneCat. No. P-T023-011CAS 1262228-27-2
ImpurityTazarotene SulfoxideCat. No. P-T023-012CAS 864841-56-5
ImpurityTazarotene Thiochromane DimerCat. No. P-T023-013CAS 1010805-73-8
ImpurityTazarotenic AcidCat. No. P-T023-014CAS 118292-41-4
ImpurityTazarotenic Acid Methyl EsterCat. No. P-T023-015CAS 1332579-70-0
ImpurityTazarotenic Acid SulfoxideCat. No. P-T023-016CAS 603952-64-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.